March 12, 2018, Santen EMEA (Geneva, Switzerland) is supporting World Glaucoma Week, from March 11 to 17, 2018, as part of its awareness activities on glaucoma.
The World Glaucoma Association holds World Glaucoma Week every March to raise awareness of the early detection and treatment of glaucoma, conducting various events and public awareness activities throughout the world during the week.
Santen considers World Glaucoma Week as a period when employees and affiliated company staff learn about glaucoma and share that knowledge with their family members and friends.
Blindness from glaucoma can often be prevented with early diagnosis and treatment. To decrease blindness from glaucoma, it is important to detect and treat the disease early and to let as many people as possible know about the need to test for glaucoma.
Vision loss and eye diseases are major global health problems that Santen has been helping tackle since 1899. We are a leader in glaucoma and dry eye disease, and our portfolio covers every severity of glaucoma, including seven glaucoma / ocular hypertension products in development.
As a specialty company dedicated to the ophthalmic field, Santen carries out research, development, marketing, and sales of pharmaceuticals. Santen is the market leader in Japan for prescription ophthalmic pharmaceuticals and sells products in approximately 60 countries. As a leading company in the field of ophthalmology, Santen aims to contribute to society by supplying valuable products and services to satisfy unmet medical needs. For more information, please visit Santen websites www.santen.com (Japan headquarters) and www.santen.eu (EMEA).